Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD8-positive, alpha-beta T cell | 7 studies | 23% ± 6% | |
regulatory T cell | 6 studies | 18% ± 3% | |
CD8-positive, alpha-beta memory T cell | 5 studies | 20% ± 2% | |
gamma-delta T cell | 5 studies | 26% ± 9% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 4 studies | 21% ± 2% | |
CD4-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
neutrophil | 3 studies | 25% ± 9% | |
natural killer cell | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of RGL4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 195.19 | 652 / 653 | 15% | 0.61 | 92 / 605 |
lung | 100% | 338.01 | 576 / 578 | 13% | 0.20 | 145 / 1155 |
pancreas | 98% | 103.50 | 323 / 328 | 12% | 0.23 | 22 / 178 |
skin | 95% | 100.70 | 1721 / 1809 | 16% | 0.33 | 74 / 472 |
kidney | 100% | 162.92 | 89 / 89 | 10% | 0.18 | 93 / 901 |
uterus | 99% | 147.05 | 169 / 170 | 11% | 0.23 | 49 / 459 |
breast | 100% | 135.84 | 459 / 459 | 8% | 0.15 | 90 / 1118 |
stomach | 99% | 109.51 | 356 / 359 | 8% | 0.14 | 24 / 286 |
bladder | 100% | 118.14 | 21 / 21 | 7% | 0.14 | 37 / 504 |
intestine | 100% | 153.28 | 964 / 966 | 6% | 0.09 | 30 / 527 |
prostate | 99% | 125.17 | 243 / 245 | 2% | 0.03 | 9 / 502 |
ovary | 100% | 201.17 | 180 / 180 | 0% | 0.01 | 1 / 430 |
adrenal gland | 100% | 123.56 | 257 / 258 | 0% | 0.01 | 1 / 230 |
spleen | 100% | 1027.14 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 141.67 | 1200 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 4041.06 | 924 / 929 | 0% | 0 | 0 / 0 |
esophagus | 96% | 89.53 | 1390 / 1445 | 1% | 0.02 | 2 / 183 |
blood vessel | 96% | 87.30 | 1276 / 1335 | 0% | 0 | 0 / 0 |
heart | 89% | 73.82 | 764 / 861 | 0% | 0 | 0 / 0 |
muscle | 87% | 73.49 | 695 / 803 | 0% | 0 | 0 / 0 |
liver | 81% | 57.77 | 183 / 226 | 4% | 0.16 | 17 / 406 |
brain | 82% | 95.07 | 2154 / 2642 | 0% | 0.01 | 3 / 705 |
lymph node | 0% | 0 | 0 / 0 | 72% | 2.72 | 21 / 29 |
tonsil | 0% | 0 | 0 / 0 | 44% | 0.72 | 20 / 45 |
eye | 0% | 0 | 0 / 0 | 4% | 0.04 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005886 | Cellular component | plasma membrane |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
Gene name | RGL4 |
Protein name | Ral-GDS-related protein (hRGR) (Ral guanine nucleotide dissociation stimulator-like 4) (RalGDS-like 4) RGL4 protein Ral guanine nucleotide dissociation stimulator like 4 |
Synonyms | RGR |
Description | |
Accessions | B5MCW5 ENST00000612432.4 ENST00000615003.4 ENST00000401461.5 E7EPT8 E9PH21 H7C063 ENST00000423392.5 A0A087X1Z6 Q495L7 A0A087WWL2 ENST00000441897.5 ENST00000290691.10 [Q8IZJ4-1] Q8IZJ4 Q3ZCN2 ENST00000452208.1 |